Prevalence and risk factors of anemia in children attending daycare centers in Belo Horizonte--MG.

Rev Bras Epidemiol

Instituto Multidisciplinar em Saúde do Campus Anísio Teixeir, Universidade Federal da Bahia, Vitória da Conquista, Bahia.

Published: September 2012

Objective: To evaluate the prevalence and risk factors of anemia in children attending daycare centers in the city of Belo Horizonte.

Methods: Cross-sectional study that evaluated 312 children aged 7 to 59 months attending daycare centers of the East Sanitary District of Belo Horizonte. The diagnosis of anemia was determined by finger stick blood samples, using the HemocueTM portable photometer, considering hemoglobin levels below 11.0 g/dL. Weight and height were measured and nutritional status of children was classified according to WHO 2006 criteria. Variables were collected through a questionnaire answered by children's parents or guardians, containing socioeconomic aspects, in addition to information on maternal and children's health. Multiple logistic regression was performed to assess the association between variables and anemia, with control for confounding variables.

Results: The prevalence of anemia in the population studied was 30.8%, with a higher prevalence in children ≤ 24 months of age (71.1%). Risk factors for anemia were age ≤ 24 months (OR: 9.08 CI: 3.96 to 20.83), and height-for-age < -1 z-score (OR: 2.1, CI: 1.20 to 3.62).

Conclusions: The high prevalence of anemia in children attending day care centers in Belo Horizonte, especially those younger than 24 months and in children with height-for-age < - 1 z-score, demonstrates the importance of nutritional care to infants and strengthens the need for commitment of child care institutions in reducing this deficiency.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s1415-790x2012000300020DOI Listing

Publication Analysis

Top Keywords

risk factors
12
factors anemia
12
anemia children
12
children attending
12
attending daycare
12
daycare centers
12
prevalence risk
8
centers belo
8
belo horizonte
8
prevalence anemia
8

Similar Publications

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression.

Gastric Cancer

January 2025

Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Menendez Pelayo nro 4 accesorio, Valencia, Spain.

Introduction: Gastric cancer (GC) burden is currently evolving with regional differences associated with complex behavioural, environmental, and genetic risk factors. The LEGACy study is a Horizon 2020-funded multi-institutional research project conducted prospectively to provide comprehensive data on the tumour biological characteristics of gastroesophageal cancer from European and LATAM countries.

Material And Methods: Treatment-naïve advanced gastroesophageal adenocarcinoma patients were prospectively recruited in seven European and LATAM countries.

View Article and Find Full Text PDF

Purpose: There is an increasing incidence of young breast cancer (YBC) patients with uncertainty surrounding the factors and patterns that are contributing.

Methods: We obtained characteristics and survival data from 206,156 YBC patients (≤ 40 years of age) diagnosed between 2005 and 2019 from the National Cancer Database (NCDB). Patients were subdivided into two comparison groups based on year of diagnosis (2005-2009, Old vs.

View Article and Find Full Text PDF

Background: Patellar instability is frequently encountered by orthopaedic surgeons. One of the major risk factors of this condition is underlying trochlear dysplasia (TD). Recent trends have indicated the use of multiple procedures to correct patellar instability under these conditions.

View Article and Find Full Text PDF

Background: Early neurological deterioration (END) is associated with a poor prognosis in acute ischemic stroke (AIS). Effectively lowering low-density lipoprotein cholesterol (LDL-C) can improve the stability of atherosclerotic plaque and reduce post-stroke inflammation, which may be an effective means to lower the incidence of END. The objective of this study was to determine the preventive effects of evolocumab on END in patients with non-cardiogenic AIS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!